Overview of the role of dystrophin in Duchenne and Beckers MD, the therapeutic options and challenges in treating neuromuscular diseases.
February 2, 2024 by Lizzie Deeble
February 2, 2024 by Lizzie Deeble
Action Duchenne
Wellesley House
Duke of Wellington Avenue Royal Arsenal
London
SE18 6SS
07535 498 506
info@actionduchenne.org